The Current Ratio of Cytodyn Inc (CYDY) is
0.26.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-05-31 |
0.26
|
| 2024-05-31 |
0.13
|
| 2023-05-31 |
0.09
|
| 2022-05-31 |
0.23
|
| 2021-05-31 |
0.85
|
| 2020-05-31 |
0.83
|
| 2019-05-31 |
0.20
|
| 2018-05-31 |
0.20
|
| 2017-05-31 |
1.00
|
| 2016-05-31 |
3.21
|
| Ticker |
Name |
Value |
|
CMPS
|
Compass Pathways PLC
|
0.77
|
|
FDMT
|
4D Molecular Therapeutics Inc
|
9.39
|
|
KROS
|
Keros Therapeutics, Inc.
|
15.45
|
|
NKTX
|
Nkarta, Inc.
|
12.69
|
|
OCGN
|
Ocugen, Inc.
|
1.06
|
|
PCVX
|
Vaxcyte, Inc.
|
7.91
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
4.16
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.82
|
|
ITOS
|
iTeos Therapeutics Inc
|
12.75
|
|
STTK
|
Shattuck Labs Inc
|
11.70
|
|
KNSA
|
Kiniksa Pharmaceuticals International, PLC
|
3.79
|
|
KRON
|
Kronos Bio LLC
|
7.54
|
|
PASG
|
Passage Bio Inc
|
2.07
|
|
QURE
|
uniQure N.V.
|
10.43
|
|
KNTE
|
Kinnate Biopharma Inc
|
13.19
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
4.41
|
|
TRIL.TO
|
Trillium Therapeutics Inc
|
13.95
|
|
DVAX
|
Dynavax Technologies Corp
|
10.80
|
|
IMVT
|
Immunovant, Inc.
|
9.09
|
|
NWBO
|
Northwest Biotherapeutics Inc
|
0.06
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
10.22
|
|
STOK
|
Stoke Therapeutics, Inc.
|
5.28
|
|
AKRO
|
Akero Therapeutics Inc
|
19.25
|
|
ANNX
|
Annexon, Inc.
|
5.68
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
3.17
|
|
KRYS
|
Krystal Biotech, Inc.
|
9.95
|
|
REPL
|
Replimune Group, Inc.
|
4.79
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
4.40
|